Kodak and PurThread Collaborate on Antimicrobial Technology for Textiles
PurThread Technologies, Inc. and Eastman Kodak Company are collaborating to bring Kodak's antimicrobial agent to the high-performance and medical textile markets.
PurThread has obtained a globally exclusive agreement to embed Kodak's antimicrobial agent into textile materials. PurThread's 2013 TechAmerica Award-winning process embeds Kodak's antimicrobial agent into synthetic fibers, before the fiber is spun into yarn and woven into fabric, ensuring that the antimicrobial effects of the fabric are uniform and constant throughout the life of the product. This proprietary antimicrobial technology is derived from Kodak's longtime expertise related to the production of photosensitive materials for use in the production of photographic products.
Currently, PurThread's product line includes healthcare textiles, such as medical scrubs, lab coats, privacy curtains and linens, as well as fitness apparel, like polo shirts and base layers. The company is also partnering with leaders in the textile industry to manufacture its products and bring this next-generation technology to discerning consumer brands.
"We are extremely pleased with the efficacy of Kodak's antimicrobial agent and their stewardship in the development of our textile technology," says Lisa Grimes, president and CEO of PurThread Technologies. "With Kodak's superior technology, our products have delivered consistently high marks for effectiveness in protecting fabrics from odor-causing organisms. We look forward to continuing research into how our textile products can play a part in comprehensive infection control strategies."
"The antimicrobial technology sector is an exciting new venture for Kodak," says Tom McHugh, general manager of materials technology and business development for Kodak's Digital Printing & Enterprise segment. "Because of PurThread's unique manufacturing process and expertise in the textile industry, we are delighted to be working with them to bring to market products using our propriety materials and technology. We look forward to building on this relationship with PurThread."
A double-blind randomized controlled trial published in December found that PurThread privacy curtains resisted contamination seven times longer than control curtains which were also eight times more likely to be contaminated with vancomycin-resistant Enterococci (VRE), compared to PurThread's curtains.
Source: PurThread Technologies Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
